Innoviva Statistics
Total Valuation
Innoviva has a market cap or net worth of $1.14 billion. The enterprise value is $1.23 billion.
| Market Cap | 1.14B |
| Enterprise Value | 1.23B |
Important Dates
The next estimated earnings date is Wednesday, May 7, 2025, after market close.
| Earnings Date | May 7, 2025 |
| Ex-Dividend Date | n/a |
Share Statistics
Innoviva has 62.68 million shares outstanding. The number of shares has decreased by -14.61% in one year.
| Current Share Class | 62.68M |
| Shares Outstanding | 62.68M |
| Shares Change (YoY) | -14.61% |
| Shares Change (QoQ) | +33.75% |
| Owned by Insiders (%) | 0.91% |
| Owned by Institutions (%) | 100.09% |
| Float | 57.83M |
Valuation Ratios
The trailing PE ratio is 50.21 and the forward PE ratio is 10.69.
| PE Ratio | 50.21 |
| Forward PE | 10.69 |
| PS Ratio | 3.13 |
| Forward PS | 4.32 |
| PB Ratio | 1.62 |
| P/TBV Ratio | 2.42 |
| P/FCF Ratio | 5.97 |
| P/OCF Ratio | 5.96 |
| PEG Ratio | n/a |
Enterprise Valuation
The stock's EV/EBITDA ratio is 5.96, with an EV/FCF ratio of 6.54.
| EV / Earnings | 52.69 |
| EV / Sales | 3.44 |
| EV / EBITDA | 5.96 |
| EV / EBIT | 6.82 |
| EV / FCF | 6.54 |
Financial Position
The company has a current ratio of 2.35, with a Debt / Equity ratio of 0.75.
| Current Ratio | 2.35 |
| Quick Ratio | 2.11 |
| Debt / Equity | 0.75 |
| Debt / EBITDA | 2.50 |
| Debt / FCF | 2.76 |
| Interest Coverage | 8.14 |
Financial Efficiency
Return on equity (ROE) is 3.42% and return on invested capital (ROIC) is 9.39%.
| Return on Equity (ROE) | 3.42% |
| Return on Assets (ROA) | 8.88% |
| Return on Invested Capital (ROIC) | 9.39% |
| Return on Capital Employed (ROCE) | 16.97% |
| Revenue Per Employee | $2.82M |
| Profits Per Employee | $184,189 |
| Employee Count | 127 |
| Asset Turnover | 0.28 |
| Inventory Turnover | 0.98 |
Taxes
In the past 12 months, Innoviva has paid $14.00 million in taxes.
| Income Tax | 14.00M |
| Effective Tax Rate | 37.43% |
Stock Price Statistics
The stock price has increased by +18.90% in the last 52 weeks. The beta is 0.57, so Innoviva's price volatility has been lower than the market average.
| Beta (5Y) | 0.57 |
| 52-Week Price Change | +18.90% |
| 50-Day Moving Average | 18.00 |
| 200-Day Moving Average | 18.38 |
| Relative Strength Index (RSI) | 64.42 |
| Average Volume (20 Days) | 1,228,785 |
Short Selling Information
The latest short interest is 8.98 million, so 14.33% of the outstanding shares have been sold short.
| Short Interest | 8.98M |
| Short Previous Month | 8.81M |
| Short % of Shares Out | 14.33% |
| Short % of Float | 15.53% |
| Short Ratio (days to cover) | 9.80 |
Income Statement
In the last 12 months, Innoviva had revenue of $358.71 million and earned $23.39 million in profits. Earnings per share was $0.36.
| Revenue | 358.71M |
| Gross Profit | 322.28M |
| Operating Income | 180.69M |
| Pretax Income | 153.00M |
| Net Income | 23.39M |
| EBITDA | 206.72M |
| EBIT | 180.69M |
| Earnings Per Share (EPS) | $0.36 |
Balance Sheet
The company has $412.50 million in cash and $520.63 million in debt, giving a net cash position of -$108.13 million or -$1.73 per share.
| Cash & Cash Equivalents | 412.50M |
| Total Debt | 520.63M |
| Net Cash | -108.13M |
| Net Cash Per Share | -$1.73 |
| Equity (Book Value) | 691.16M |
| Book Value Per Share | 11.03 |
| Working Capital | 318.22M |
Cash Flow
In the last 12 months, operating cash flow was $188.69 million and capital expenditures -$270,000, giving a free cash flow of $188.42 million.
| Operating Cash Flow | 188.69M |
| Capital Expenditures | -270,000 |
| Free Cash Flow | 188.42M |
| FCF Per Share | $3.01 |
Margins
Gross margin is 89.84%, with operating and profit margins of 50.37% and 6.52%.
| Gross Margin | 89.84% |
| Operating Margin | 50.37% |
| Pretax Margin | 10.42% |
| Profit Margin | 6.52% |
| EBITDA Margin | 57.63% |
| EBIT Margin | 50.37% |
| FCF Margin | 52.53% |
Dividends & Yields
Innoviva does not appear to pay any dividends at this time.
| Dividend Per Share | n/a |
| Dividend Yield | n/a |
| Dividend Growth (YoY) | n/a |
| Years of Dividend Growth | n/a |
| Payout Ratio | n/a |
| Buyback Yield | 14.61% |
| Shareholder Yield | 14.61% |
| Earnings Yield | 2.08% |
| FCF Yield | 16.76% |
Analyst Forecast
The average price target for Innoviva is $55.00, which is 202.53% higher than the current price. The consensus rating is "Buy".
| Price Target | $55.00 |
| Price Target Difference | 202.53% |
| Analyst Consensus | Buy |
| Analyst Count | 1 |
| Revenue Growth Forecast (5Y) | n/a |
| EPS Growth Forecast (5Y) | n/a |
Stock Splits
This stock does not have any record of stock splits.
| Last Split Date | n/a |
| Split Type | n/a |
| Split Ratio | n/a |
Scores
Innoviva has an Altman Z-Score of 2.09 and a Piotroski F-Score of 7. A Z-score under 3 suggests an increased risk of bankruptcy.
| Altman Z-Score | 2.09 |
| Piotroski F-Score | 7 |